Here we show that mouse IgG2a and IgG1 antibodies specific for the commensal Streptococcus mitis cross-react with the pathogen Streptococcus pneumoniae, although the cross-reactivity conferred by IgG2a is stronger than IgG1 antibodies. These findings may have implications for designing S. mitis-based vaccines against pneumococcal infections.
Introduction
Streptococcus pneumoniae, a gram-positive bacterium that resides in the human upper respiratory tract, causes several diseases worldwide, such as pneumonia, sepsis, meningitis, and otitis media. 1 Due to differences in polysaccharide capsules, S. pneumoniae has been classified into more than 90 serotypes, which reflect different antigenicity and geographical distribution. 2 Current pneumococcal vaccines are effective against only those S. pneumoniae serotypes that are included in vaccines. 2 This underscores the exploration of alternative prophylactic strategies that provide protection against all serotypes. In recent years,
Streptococcus mitis, a commensal that shares phylogenetic, antigenic, and ecological characteristics with S. pneumoniae, has appeared as an interesting vaccine candidate that holds the potential to confer optimal immunity to pneumococcal infections. 3, 4 Although recent studies have indicated a crucial role for IgG antibodies in defense against pneumococcal infections, it is unclear as to how S. mitis stimulates the host's immune system to generate humoral responses. 5 Emerging evidence reveals that rabbits immunized with S. mitis generate IgG antibodies that are reactive with both S. mitis and S. pneumoniae. 4 In line with this, we have recently shown that mouse IgG antibodies specific for S. mitis exhibited cross-reactivity toward S. pneumoniae strains D39 (serotype 2) and TIGR4 
Material and methods

Bacterial culture and lysis
The bacterial strains used in this study included S. mitis CCUG31611 (type strain, equivalent to NCTC12261), S. pneumoniae D39 (serotype 2), and S. pneumoniaeTIGR4 (serotype 4).
All strains were cultured, harvested, and stored as described previously. 4 To lyse the bacterial cells, a Precellys Lysing Kit and Homogenizer (Precellys 24, Bertin Instruments) was used as per the manufacturer's instructions. After homogenization, the bacterial cell lysate was centrifuged at 1,000 g for 5 min at 4°C and the supernatant was collected and stored at −80°C for further use. The total protein in the cell lysate was quantified using BCA Protein Assay Kit (ThermoFischer Scientific).
Mouse immunization
CD1 mice used in this study were females of 6-8 weeks age. These mice were specific pathogen free (SPF) and housed in a Minimal Disease Unit at the animal facility at Oslo University Hospital, Rikshospitalet, Oslo, Norway. All animal experiments were approved by the Norwegian Food Safety Authority, Oslo, Norway (Project license number FOTS -8481).
The mice were intranasally immunized with 5 x 10 7 colony forming units (CFU) of S. mitis in 20 µl of PBS or 20 µl of PBS (sham) for each mouse at days 0, 14, and 21. The mice were euthanized at day 7 after the last immunization to collect the blood via intracardiac injection.
The freshly isolated blood was kept at 4 0 C for 1 hour and then centrifuged at 1000g for 5 minutes. The supernatant sera were collected and preserved at -80 0 C refrigerator for further analysis.
Western blotting
As descried previously, 3 SDS-PAGE-separated proteins were transferred from gradient gels 
Whole cell ELISA
To determine antibody levels in mouse sera samples, a whole cell ELISA was used as described previously. 4 In brief, each well of a 96-well plate (Maxisorb, Nunc, Thermo Scientific) was coated overnight with 100 µl of bacterial suspension (OD600 0.5), which was washed and then fixed with 10% formalin. The plate was washed and blocked with a blocking buffer (PBS + 0.05% Tween + 1% BSA) and incubation for 1 h at 37°C. Antisera were diluted (1:100) and added to wells in duplicate, incubated for 2 h at room temperature before addition of the anti-mouse IgG2a/HRP or anti-IgG1/HRP secondary antibody (1:10,000)
followed by incubation for 2 h at room temperature. The plates were washed and 100 µl of TMB substrate (ThermoFisher Scientific, Rockford, IL, USA) was added to each well. The plate absorbance was measured by reading the plates at 450 nm using a Multi Mode reader (BioTek™ Cytation™ 3; ThermoFischer Scientific).
Statistics
Unpaired Student's t test was used to compare two groups of mice (GraphPad Prism
Software, version 8, Graph Pad, San Diego, CA, USA). A p value less than 0.05 was considered significant.
Results
Our Western blotting showed that serum IgG2a and IgG1 antibodies from the S. mitisimmunized mice cross-reacted with multiple proteins of S. pneumoniae D39 and TIGR4. This was reflected by several visible bands that were between 25 to 75 kD ( Figure 1A ). Two prominent bands were present at around 250 and 25 kD in the membrane lane loaded with S.
mitis, but not S. pneumoniae serotypes ( Figure 1A ). Compared to IgG2a, IgG1 antibodies from the immunized mice showed weaker reactivity toward S. mitis and S. pneumoniae ( Figure 1A ). However, IgG2a and IgG1 antibodies from the mice inoculated with PBS (control mice) gave rise to few faint bands ( Figure 1A ). Of note, our data also reflected similar findings in the nasal wash and bronchoalveolar lavage of immunized mice (data not shown).
We further measured the levels of serum IgG2a and IgG1 antibodies reactive to S.
pneumoniae using a whole cell ELISA assay. The S. mitis-immunized mice displayed significantly higher levels of IgG2 antibodies reactive to S. mitis and S. pneumoniae D39 and TIGR4 than IgG1 antibodies ( Figure 1B ). Taken together, these findings reveal that following mucosal immunization with S. mitis, mice generate enhanced IgG2a and IgG1 antibody responses that cross-react with S. pneumoniae serotypes, although the IgG2a responses are stronger than IgG1 responses.
Discussion
In this study, we have for the first time shown that serum IgG2a and IgG1 antibody isotypes induced in response to immunization of mice with S. mitis cross-react with S. pneumoniae serotypes, and that the cross-reactivity induced by IgG2a is stronger than IgG1 antibodies.
Mouse IgG2a antibody is considered as a functional equivalent of human IgG1 antibodies, which constitute the most abundant among all serum IgG isotypes. 
Conflict of interest statement
The authors declare that there are no conflicts of interest. sham-treated and immunized mice. **p<0.01; ***p<0.001. Abbreviations: ns = not significant; D39 -S. pneumoniae D39; TIGR4 -S. pneumoniae TIGR4.
